Erschienen in:
04.03.2019 | Correspondence
High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis
Erschienen in:
Digestive Diseases and Sciences
|
Ausgabe 5/2019
Einloggen, um Zugang zu erhalten
Excerpt
To the Editors, We read with interest the article by Chao et al. [
1] evaluating the intensified infliximab (IFX) induction on colectomy rate and identifying outcome predictors in acute severe ulcerative colitis (ASUC). The author found that the use of high-dose IFX rescue therapy did not improve 3-month colectomy-free survival in ASUC patients. Because the findings of Che-Yung Chao’s study are different from previous studies, several questions deserve attention. …